The Whole Exome Solution (WES) of Sophia Genetics covers the coding regions (± 5 bp of the intron regions) of more than 19,000 RefSeq genes, allowing a complete study of the patient’s genes.

The kit uses NGS capture technology and is intended for use on Illumina platforms. The results are interpreted in the SOPHiA DDM platform, designed for the analysis and protection of NGS clinical data in routine diagnosis.

It also allows the detection of SNV and Indels, and guarantees a high percentage of readings in the target and uniformity of coverage, even in regions rich in GC.

kit-SOPHiA-DDM-CES

 SOPHiA analyzes complex NGS genomic data through the detection, annotation and pre-classification of genomic variants to help clinicians better diagnose their patients.

In addition to the Whole Exome Solution, we have other more specific panels for clinical diagnosis in areas such as metabolism, oncology, genetics or cardiology.

Area:

Exomes, Hereditary and/or Rare Diseases, Molecular Genetics

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Clinical Exome Solution (CES v3)

Analysis of 4,728 genes related to rare and hereditary disorders.
Next Generation Sequencing (NGS)

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)